Enrotron 100mg/ml Oral Solution 1 Litre
Enrotron 100mg/ml oral solution is used for the treatment of infections caused by the following bacteria susceptible to enrofloxacin: Chickens - Mycoplasma gallisepticum, Mycoplasma synoviae, Avibacterium -paragallinarum, Pasteurella multocida and Escherichia coli. Turkeys Mycoplasma gallisepticum, Mycoplasma synoviae, Pasteurella multocida and Escherichia coli. Rabbits - For the treatment of infectious diseases due to Pasteurella multocida and bacterial enteritis due to infection with E. coli. Enrofloxacin should be used where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the active substance of choice.
Original: $170.99
-70%$170.99
$51.30Enrotron 100mg/ml Oral Solution 1 Litre
Enrotron 100mg/ml oral solution is used for the treatment of infections caused by the following bacteria susceptible to enrofloxacin: Chickens - Mycoplasma gallisepticum, Mycoplasma synoviae, Avibacterium -paragallinarum, Pasteurella multocida and Escherichia coli. Turkeys Mycoplasma gallisepticum, Mycoplasma synoviae, Pasteurella multocida and Escherichia coli. Rabbits - For the treatment of infectious diseases due to Pasteurella multocida and bacterial enteritis due to infection with E. coli. Enrofloxacin should be used where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the active substance of choice.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
Enrotron 100mg/ml oral solution is used for the treatment of infections caused by the following bacteria susceptible to enrofloxacin: Chickens - Mycoplasma gallisepticum, Mycoplasma synoviae, Avibacterium -paragallinarum, Pasteurella multocida and Escherichia coli. Turkeys Mycoplasma gallisepticum, Mycoplasma synoviae, Pasteurella multocida and Escherichia coli. Rabbits - For the treatment of infectious diseases due to Pasteurella multocida and bacterial enteritis due to infection with E. coli. Enrofloxacin should be used where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the active substance of choice.
